BioSig Technologies, Inc.
BSGM
$4.58
$0.00760.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.34% | 81.83% | 58.09% | 64.71% | 53.60% |
| Total Depreciation and Amortization | -60.00% | -58.24% | -7.93% | -23.03% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.63% | -343.52% | 1,506.33% | -3.13% | -38.02% |
| Change in Net Operating Assets | -202.85% | 511.76% | -642.93% | -16,847.62% | 210.88% |
| Cash from Operations | 15.14% | 83.89% | 61.10% | 69.74% | 76.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 351.92% | -99.96% | -100.00% | -2.34% | -84.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 205.19% | -99.96% | -100.00% | -34.14% | -77.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,486.28% | -137.69% | -72.54% | 1,155.00% | -78.58% |